Level Biotechnology Inc. (3118.TWO)
TWD 31.0
(-1.12%)
TWD 31.0
(-1.12%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 273.2 Million TWD | 1.14% |
| 2022 | 270.12 Million TWD | 11.27% |
| 2021 | 242.77 Million TWD | -0.32% |
| 2020 | 243.55 Million TWD | 3.01% |
| 2019 | 236.42 Million TWD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 269.61 Million TWD | -1.31% |
| 2024 Q2 | 309.54 Million TWD | 14.81% |
| 2023 Q4 | 273.2 Million TWD | 4.82% |
| 2023 FY | 273.2 Million TWD | 1.14% |
| 2023 Q1 | 269.33 Million TWD | -0.29% |
| 2023 Q2 | 306.73 Million TWD | 13.88% |
| 2023 Q3 | 260.64 Million TWD | -15.03% |
| 2022 Q4 | 270.12 Million TWD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 583.48 Million TWD | 53.177% |
| Sagittarius Life Science Corp | 137.82 Million TWD | -98.225% |
| NeoCore Technology Co., Ltd. | 197.47 Million TWD | -38.35% |
| TaiMed Biologics Inc. | 1.32 Billion TWD | 79.425% |
| GlycoNex Incorporation | 276.39 Million TWD | 1.157% |
| VBI | 21.25 Million TWD | -1185.591% |
| GeneReach Biotechnology Corp. | 313.7 Million TWD | 12.912% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 514.65 Million TWD | 46.915% |
| Visgeneer Inc. | 185.6 Million TWD | -47.195% |
| Mycenax Biotech Inc. | 1.32 Billion TWD | 79.353% |
| Sunmax Biotechnology Co., Ltd. | 732.98 Million TWD | 62.728% |
| G&E Herbal Biotechnology Co., Ltd. | 119.86 Million TWD | -127.933% |
| Medigen Vaccine Biologics Corporation | 2.24 Billion TWD | 87.836% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 6.61 Million TWD | -4028.15% |
| Enimmune corporation | 173.46 Million TWD | -57.498% |
| TaiRx, Inc. | 60.62 Million TWD | -350.641% |
| CHO Pharma, Inc. | 110.83 Million TWD | -146.5% |
| EirGenix Inc. | 1.14 Billion TWD | 76.142% |
| BioLASCO Taiwan Co., Ltd. | 111.98 Million TWD | -143.971% |
| Sunny Pharmtech Inc. | 512.43 Million TWD | 46.686% |
| Lin BioScience, Inc. | 167.73 Million TWD | -62.881% |
| BioGend Therapeutics Co., Ltd. | 93.71 Million TWD | -191.526% |
| Feng Chi Biotech Corp. | 63.03 Million TWD | -333.418% |
| Bio Preventive Medicine Corp. | 124.72 Million TWD | -119.036% |
| Lukas Biomedical Inc. | 161.05 Million TWD | -69.628% |
| RBC Bioscience Corporation | 513.08 Million TWD | 46.753% |
| BiOptic Inc. | 170.56 Million TWD | -60.176% |
| BRIM Biotechnology, Inc. | 42.15 Million TWD | -548.041% |
| Shine-On BioMedical Co.,Ltd. | 23.25 Million TWD | -1074.805% |
| Great Novel Therapeutics Biotech & Medicals | 26.81 Million TWD | -918.912% |
| Syngen Biotech Co.,Ltd. | 974.63 Million TWD | 71.969% |
| Anti-Microbial Savior BioteQ Co., Ltd | 6.99 Million TWD | -3806.22% |
| SynCore Biotechnology Co.,Ltd | 21.22 Million TWD | -1187.105% |
| Genomics BioSci & Tech. Co.,Ltd. | 368.33 Million TWD | 25.827% |
| Neith Corporation | 17.43 Million TWD | -1467.149% |
| Advagene Biopharma Co., Ltd. | 7.97 Million TWD | -3327.007% |
| NaviFUS Corp. | 53.4 Million TWD | -411.603% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 481.48 Million TWD | 43.259% |
| Sinew Pharma Inc. | 39.71 Million TWD | -587.921% |
| Andros Pharmaceuticals Co.,Ltd | 58.03 Million TWD | -370.72% |
| Greenyn Biotechnology Co., Ltd | 364.47 Million TWD | 25.043% |
| Lumosa Therapeutics Co., Ltd. | 227.69 Million TWD | -19.986% |
| AP Biosciences Inc | 106.65 Million TWD | -156.166% |
| Medigen Biotechnology Corp. | 3.53 Billion TWD | 92.261% |
| 3D Global Biotech Inc. | 30.68 Million TWD | -790.457% |
| Pharmosa Biopharm Inc. | 195.99 Million TWD | -39.395% |
| Intech Biopharm Corporation | 1.54 Billion TWD | 82.297% |
| Oneness Biotech Co., Ltd. | 866.42 Million TWD | 68.468% |
| Eusol Biotech Co.,Ltd. | 9.27 Million TWD | -2845.246% |
| TWi Biotechnology, Inc. | 55.81 Million TWD | -389.493% |
| Ever Supreme Bio Technology Co., Ltd | 232.95 Million TWD | -17.274% |
| TCI GENE Inc. | 155.54 Million TWD | -75.638% |
| MegaPro Biomedical Co., Ltd | 25.5 Million TWD | -971.04% |
| Senhwa Biosciences, Inc. | 46.17 Million TWD | -491.664% |
| Taiwan Bio Therapeutics Co., Ltd | 328.47 Million TWD | 16.826% |
| NatureWise Biotech & Medicals Corporation | 64.88 Million TWD | -321.041% |
| PharmaEngine, Inc. | 91 Million TWD | -200.201% |
| Savior Lifetec Corporation | 457.95 Million TWD | 40.344% |
| TaiGen Biopharmaceuticals Holdings Limited | 110.94 Million TWD | -146.26% |
| OBI Pharma, Inc. | 650.44 Million TWD | 57.998% |
| Meribank Biotech Co., Ltd | 390.81 Million TWD | 30.094% |
| Acepodia, Inc. | 384.47 Million TWD | 28.941% |
| Caliway Biopharmaceuticals Co., Ltd. | 85.55 Million TWD | -219.335% |